Theoretical and practical issues concerning the use of rhGM-CSF and rhIL-3: present status.
Jones
T C
TC
Clinical Research, Sandoz Ltd., Basle, Switzerland.
D016026:Bone Marrow Transplantation; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D004341:Drug Evaluation; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000627:therapeutic use*; D006402:Hematologic Diseases / Q000628:therapy; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D007377:Interleukin-3 / Q000627:therapeutic use*; D009369:Neoplasms / Q000628:therapy
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D007377:Interleukin-3; D016178:Granulocyte-Macrophage Colony-Stimulating Factor